Bencić M L, Milicić D, Kosi D, Gras D, Ferek-Petrić B, Buljević B, Goldner V
Klinicki bolnicki centar, Zagreb.
Lijec Vjesn. 2000 May-Jun;122(5-6):127-31.
Over the past few years, indications for permanent cardiac pacing have been broadened. Accordingly, American Heart Association and American College of Cardiology included dilated cardiomyopathy, hypertrophic obstructive cardiomyopathy and pacing for prevention of atrial fibrillation into indications for permanent cardiac pacing. Studies have described favourable effect of dual chamber cardiac pacing in congestive heart failure in dilated cardiomyopathy, regardless of etiology. In the past two years, even more beneficial effect was associated with multisite, biventricular cardiac pacing. On the basis of the reported results, a multisite pacemaker InSync was implanted to a patient with dilated cardiomyopathy (NYHA class IV), who was also on the list for heart transplantation, and who fulfilled other criteria for implantation of multisite pacemaker. During the eleven-month follow-up, functional improvement, better 6-minute walking test and enhanced quality of life of the patient were observed, which is in accordance with the literature data.
在过去几年中，永久性心脏起搏的适应证有所拓宽。相应地，美国心脏协会和美国心脏病学会将扩张型心肌病、肥厚性梗阻性心肌病以及预防心房颤动的起搏纳入永久性心脏起搏的适应证。研究描述了双腔心脏起搏对扩张型心肌病所致充血性心力衰竭的有益作用，无论其病因如何。在过去两年中，多部位双心室心脏起搏显示出更为有益的效果。基于所报道的结果，为一名扩张型心肌病（纽约心脏协会心功能IV级）患者植入了多部位起搏器InSync，该患者也在心脏移植等候名单上，且符合植入多部位起搏器的其他标准。在11个月的随访期间，观察到患者功能改善、6分钟步行试验结果更佳且生活质量提高，这与文献数据相符。
